(19)
(11) EP 4 770 646 A1

(12)

(43) Date of publication:
08.07.2026 Bulletin 2026/28

(21) Application number: 24762306.9

(22) Date of filing: 28.08.2024
(51) International Patent Classification (IPC): 
A61K 31/5377(2006.01)
A61P 35/00(2006.01)
A61K 45/06(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/5377; A61K 45/06; A61P 35/00
(86) International application number:
PCT/EP2024/073974
(87) International publication number:
WO 2025/045901 (06.03.2025 Gazette 2025/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 31.08.2023 EP 23194748
29.09.2023 EP 23200990

(71) Applicant: F. Hoffmann-La Roche AG
4070 Basel (CH)

(72) Inventors:
  • ARCHER, Venice Rosalie
    Garden City Hertfordshire AL7 1TW (GB)
  • BORDOGNA, Walter
    4070 Basel (CH)
  • CARDONA GAVALDON, Andres
    4070 Basel (CH)
  • GOLDING, Sophie Maude Alice
    4070 Basel (CH)
  • MAUDIRE ÉPOUSE HILTON, Magalie
    4070 Basel (CH)
  • NOÉ, Johannes Alexander
    4070 Basel (CH)
  • OCHI LOHMANN, Tania Helena
    4070 Basel (CH)
  • RUF, Thorsten
    4070 Basel (CH)
  • XU, Tingting
    Shanghai 201203 (CN)
  • ZEAITER, Ali
    4070 Basel (CH)

(74) Representative: D Young & Co LLP 
3 Noble Street
London EC2V 7BQ
London EC2V 7BQ (GB)

   


(54) TREATMENT OF NON SMALL CELL LUNG CANCER WITH ALECTINIB